Zepp Health [ZEPP] vs Apple [AAPL] Detailed Stock Comparison

Zepp Health Corporation

NYSE
Loading...

Apple Inc.

NASDAQ
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Zepp Health Corporation wins in 5 metrics, Apple Inc. wins in 13 metrics, with 0 ties. Apple Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Zepp Health Corporation Apple Inc. Better
P/E Ratio (TTM) -6.56 34.35 Apple Inc.
Price-to-Book Ratio 1.20 45.19 Zepp Health Corporation
Debt-to-Equity Ratio 54.21 102.63 Zepp Health Corporation
PEG Ratio 0.09 1.88 Zepp Health Corporation
EV/EBITDA -175.77 26.18 Apple Inc.
Profit Margin (TTM) -15.48% 27.04% Apple Inc.
Operating Margin (TTM) -4.55% 35.37% Apple Inc.
EBITDA Margin (TTM) N/A 35.37% N/A
Return on Equity -17.15% 152.02% Apple Inc.
Return on Assets (TTM) -3.34% 24.38% Apple Inc.
Free Cash Flow (TTM) $-25.88M $98.77B Apple Inc.
Dividend Yield N/A 0.48% N/A
1-Year Return 103.03% 48.20% Zepp Health Corporation
Price-to-Sales Ratio (TTM) 0.91 9.14 Zepp Health Corporation
Enterprise Value $4.26B $4,003.07B Apple Inc.
EV/Revenue Ratio 16.44 9.19 Apple Inc.
Gross Profit Margin (TTM) N/A 48.16% N/A
Revenue per Share (TTM) $16 $29 Apple Inc.
Earnings per Share (Diluted) $-2.56 $7.89 Apple Inc.
Beta (Stock Volatility) 1.77 1.11 Apple Inc.
Short % of Float 7.68% 0.92% Apple Inc.

Zepp Health Corporation vs Apple Inc. Stock Performance Analysis

Loading Price Chart...

ZEPP
AAPL

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Zepp Health Corporation7.46%-18.45%-50.83%-68.93%-82.20%-82.02%
Apple Inc.0.14%5.84%13.40%23.50%35.28%23.15%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Zepp Health Corporation103.03%0.21%-89.23%-89.70%-89.70%-89.70%
Apple Inc.48.20%57.44%123.16%1,121.70%2,444.84%14,032.52%

Performance & Financial Health Analysis: Zepp Health Corporation vs Apple Inc.

MetricZEPPAAPL
Market Information
Market Cap i$245.12M$3.98T
Market Cap CategoryMicro capMega cap
10 Day Avg. Volume i55,85244,085,150
90 Day Avg. Volume i108,17141,911,970
Last Close$5.04$333.74
52 Week Range$2.25 - $61.85$201.50 - $334.98
% from 52W High-91.85%-0.37%
All-Time High$81.00 (Feb 15, 2021)$334.98 (Jul 17, 2026)
% from All-Time High-93.78%-0.37%
Growth Metrics
Quarterly Revenue Growth0.43%0.16%
Quarterly Earnings GrowthN/A0.16%
Financial Health
Profit Margin (TTM) i-0.15%0.27%
Operating Margin (TTM) i-0.05%0.35%
Return on Equity (TTM) i-0.17%1.52%
Debt to Equity (MRQ) i54.21102.63
Cash & Liquidity
Book Value per Share (MRQ)$13.51$6.00
Cash per Share (MRQ)$0.23$4.56
Operating Cash Flow (TTM) i$-25,970,000$135.47B
Levered Free Cash Flow (TTM) i$-116,647,485$106.31B
Dividends
Last 12-Month Dividend Yield iN/A0.48%
Last 12-Month Dividend i$0.00$1.29

Valuation & Enterprise Metrics Analysis: Zepp Health Corporation vs Apple Inc.

MetricZEPP (Apr 26, 2026)AAPL (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i-6.5634.35
Forward P/E i231.1428.92
PEG Ratio i0.091.88
Price to Sales (TTM) i0.919.14
Price to Book (MRQ) i1.2045.19
Market Capitalization
Market Capitalization i$245.12M$3.98T
Enterprise Value i$4.26B$4.00T
Enterprise Value Metrics
Enterprise to Revenue i16.449.19
Enterprise to EBITDA i-175.7726.18
Risk & Other Metrics
Beta i1.771.11
Book Value per Share (MRQ) i$13.51$6.00

Financial Statements Comparison: Zepp Health Corporation vs Apple Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricZEPP (2025)AAPL (2025)
Revenue/Sales iN/A416.16B
Cost of Goods Sold iN/A220.96B
COGS % of Revenue i-53.1%
Gross Profit iN/A195.20B
Gross Margin i-46.9%
Research & Development iN/A34.55B
Operating Income (EBIT) iN/A133.05B
Operating Margin i-32.0%
EBITDA iN/A144.75B
EBITDA Margin i-34.8%
Pre-Tax Income iN/A132.73B
Pre-Tax Income % of Revenue i-31.9%
Income Tax iN/A20.72B
Income Tax % of Revenue i-5.0%
Net Income (Profit) iN/A112.01B
Profit Margin i-26.9%

Balance Sheet & Liquidity Metrics

MetricZEPP (2025)AAPL (2025)
Cash & Equivalents i91.07M35.93B
Total Current Assets i251.56M147.96B
Total Current Assets % of Revenue i-35.6%
Total Current Liabilities i195.37M165.63B
Total Current Liabilities % of Revenue i-39.8%
Long-Term Debt i77.25M78.33B
Long-Term Debt % of Revenue i-18.8%
Total Shareholders Equity i252.73M73.73B
Retained Earnings i28.62M-14.26B
Retained Earnings % of Revenue i--3.4%
Property, Plant & Equipment i3.46M0

Cash Flow Statement Comparison

MetricZEPP (2025)AAPL (2025)
Operating Cash Flow i-25.97M111.48B
Operating Cash Flow % of Revenue i-26.8%
Capital Expenditures i-707,000-12.72B
Free Cash Flow i-25.88M98.77B
FCF Margin i-23.7%
Debt Repayment i-12.60M-10.93B
Common Stock Repurchase i-2.28M-90.71B

Short Interest & Institutional Ownership Analysis

MetricZEPPAAPL
Shares Short i463,069134.42M
Short Ratio i4.163.24
Short % of Float i7.68%0.92%
Shares Outstanding i7.04M14.70B
Float Shares i96.40M14.66B
% Held by Insiders i7.64%1.64%
% Held by Institutions i63.11%65.23%
% Held by Public i29.25%33.13%

Dividend Analysis & Yield Comparison: Zepp Health Corporation vs Apple Inc.

MetricZEPPAAPL
Last 12-Month Dividend i$0.00$1.29
Last 12-Month Dividend Yield iN/A0.48%
3-Year Avg Annual Dividend i$0.00$1.08
3-Year Avg Dividend Yield iN/A0.12%
3-Year Total Dividends i$0.00$3.23
Ex-Dividend DateN/AFeb 09, 2026